CHARLESTON, S.C., June 22, 2011 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB:RMCP) will be an exhibitor at the 2011 Defense Logistics Agency (DLA) Industry Conference from June 27 - 30th in Columbus, Ohio. The 2011 DLA Industry Conference will feature speakers and panelists from the Department of Defense, military services, DLA and other government agencies and industries.
"DLA is our military's supply chain authority, processing over 116,000 requisitions and nearly 10,000 contract actions daily," stated Ron Wheet, Chief Executive Officer of Revolutions Medical. "The theme of this year's conference is 'Sustaining Warfighter Support While Reducing Cost,' which directly mirrors RevVac's core capabilities. We are keenly focused on demonstrating value to DLA's Medical/Surgical Commodity Business Unit."
"Now that we are teamed with Revolutions Medical Corporation, one of our initial sales targets is the $4.5B annual spend on medical material within the DLA," stated Elvis Oxley, President of Oxley Consulting, LLC of Washington, DC. He added, "Exhibiting at DLA's annual procurement conference and introducing the RevVac Auto Retractable Safety Syringe to DLA's key procurement personnel are essential first steps to gain market share within the Department of Defense."
The host of the conference is Vice Admiral Alan Thompson, Director of the Defense Logistics Agency. Last year's conference was attended by over 3,000 people and included more than 230 exhibits.
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its products include the RevVac™ Safety Syringe (FDA cleared), safety blood drawing device, the RevColor™, RevDisplay™ and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS).
For additional information, please visit Revolutions Medical corporate website:
To be added to the Revolutions Medical investor email list, please email: [email protected] with RMCP in the subject line.
Become a RevMed fan and follow the Company on Facebook – visit: http://www.Facebook.com/Revmed
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
CONTACT: Revolutions Medical Corporation Investor and Corporate Relations Gregory S. Lowe Acorn Management Partners President / Partner 678-368-4013
